Title: Reproducibility and Clinical Concordance of a Tumor-Informed MRD Assay in Patients with Resected Colorectal Cancer from the DYNAMIC Trials Abstract Number: 26 Lead Author: Jeanne Tie, MBChB, FRACP, MD Session Time and Date: 1/10/2026, 12:00 PM-1:30 PM (PST) SECAUCUS, N.J., Jan. 6, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing dur ...